Learning outcomes
By the end of this lesson you should be able to: explain the principle behind a serum enzyme assay; state the timing rules that govern the interpretation of cardiac and hepatic markers; distinguish a liver enzyme pattern from a biliary one using a paired test; identify the clinical questions a serial assay can answer; and explain what a laboratory's reference range actually means and how to interpret a result that falls just outside it.
Prerequisites
Lesson 4 (Enzymes and Michaelis-Menten kinetics). You need Km, Vmax and the concept of enzyme specificity, because an assay measures a rate and that rate is interpreted through the enzyme's kinetic properties.
The big idea
The logic is simple and it works everywhere in clinical medicine. A healthy cell keeps its enzymes inside. A damaged cell leaks them. The blood that drains the damaged organ therefore carries a sample of what that organ was made of. An assay is not measuring the disease itself; it is measuring the wreckage, and like all wreckage it takes time to appear, time to peak and time to clear.
The principle behind the assay
The laboratory adds the patient's serum to a controlled reaction mixture and watches a product appear or a substrate disappear, usually by following the change in absorbance of a coenzyme with a spectrophotometer. The measurement is a rate — enzyme units per litre — and that rate is only meaningful if the assay conditions are fixed: substrate concentration, pH, temperature, and the presence of any required cofactors. That is why results are reported against a reference range measured in the same conditions, and why a result from a different laboratory with a different method is not directly comparable.
NoteBecause the assay measures a rate, 'high enzyme' means either more enzyme molecules or a more active enzyme. In tissue injury the mechanism is always more enzyme molecules, released by damaged cells.
Worked example: reading a cardiac marker series
A 58-year-old man presents to the emergency department with an hour of central chest pain. Serial measurements of troponin are taken on arrival and again at intervals afterwards. The first value is normal, and the second is eight times the upper limit of normal.
| Marker | Rises | Peaks | Returns to baseline | What it is best for |
|---|---|---|---|---|
| Troponin I and T | About 3 to 6 hours | About 24 hours | About 5 to 14 days | Diagnosing a first infarction, and detecting any myocardial necrosis |
| CK-MB | About 3 to 6 hours | About 24 hours | About 48 to 72 hours | Detecting a new infarction in a patient whose troponin is still elevated |
| Myoglobin | Within about 1 to 2 hours | About 8 hours | About 24 hours | Early screening — it rises first, but is not specific to cardiac muscle |
The first normal troponin teaches the most important lesson of the series: a normal value early does not exclude a myocardial infarction, because the enzyme has not yet leaked out and been cleared. This is why the diagnosis is built on the pattern of change — a rise and then a fall — rather than on any single value, and why a mandatory delay exists between the two measurements. The one exception is a troponin that rises and then falls again in a patient whose first infarction was several days ago: that pattern can only be a second event, and CK-MB is the marker that is used, because it clears fast enough to rise again.
A patient's troponin is 0.8 units per litre on arrival at one hour after the onset of chest pain. Does that exclude a myocardial infarction?
Worked example: liver versus biliary
A patient is jaundiced. The laboratories return a raised aspartate aminotransferase and alanine aminotransferase, together with a markedly raised alkaline phosphatase and a raised gamma-glutamyl transferase. What distinguishes the patterns?
| Pattern | Dominant enzymes | Site of the problem |
|---|---|---|
| Hepatocellular | AST and ALT raised much more than alkaline phosphatase | The liver cells themselves — viral hepatitis, paracetamol overdose, ischaemia, alcohol |
| Cholestatic (obstructive) | Alkaline phosphatase and gamma-glutamyl transferase raised much more than AST and ALT | The bile ducts — a stone in the common bile duct, a tumour, primary biliary cirrhosis |
The reason the two tests are used together is that alkaline phosphatase is not specific to the liver: it is also abundant in bone, in placenta, and in kidney. A pregnant woman, a growing adolescent with active bone, and a patient with Paget's disease can all have a raised alkaline phosphatase. The gamma-glutamyl transferase is the hepatic confirmatory test, so a parallel rise localises the alkaline phosphatase to the liver.
Two further points of technique. First, an AST that is twice the ALT or more suggests an alcoholic origin, because alcohol damages the mitochondria and depletes the cofactor required to synthesise ALT. Second, in extremely severe hepatitis the enzyme levels can paradoxically fall, because the liver has run out of cells to leak — the 'burning out' hepatitis, in which a falling AST with a rising bilirubin and a rising prothrombin time is a prognostic warning rather than reassurance.
Reference ranges and clinical judgment
A reference range is conventionally defined as the interval containing 95 per cent of healthy people, which means about 2.5 per cent of perfectly well individuals fall outside it at either end by construction. A mildly abnormal result is therefore a probability statement, not a diagnosis, and it must be read with the clinical picture. A creatine kinase of twice the upper limit in a marathon runner the day after a race is the expected effect of muscle strain; the same value in a patient at rest is a reason to question the urine output and check for rhabdomyolysis.
Watch outThe commonest interpretive error is to act on a single value without a timeline. Many assays are only interpretable as a series: cardiac markers, transaminases, and renal function all need the direction and rate of change, not just the magnitude.
Common mistakes
Watch outAttributing a raised ALT to the heart. ALT is more liver-specific; the cardiac markers are troponin and CK-MB. AST is shared between liver and muscle, which is why ALT is the more specific liver enzyme.
Watch outReporting an enzyme value as a concentration of 'harmful enzyme' in the blood. The enzyme is a normal intracellular constituent; the number reports the amount of damage, not toxicity.
Watch outUsing a jaundiced patient's raised alkaline phosphatase to diagnose biliary obstruction without checking gamma-glutamyl transferase and a liver ultrasound. Bone disease and pregnancy also raise the alkaline phosphatase.
Check your understanding
Why do plasma enzyme and protein assays help after a suspected heart attack?
In a jaundiced patient, which pair of enzymes distinguishes a hepatocellular pattern from an obstructive one?
Why does the CK-MB fall faster than troponin after a myocardial infarction?
Multiple choice
Why do plasma enzyme assays help after a suspected myocardial infarction?
A jaundiced patient has AST 320 units per litre, ALT 410 units per litre, alkaline phosphatase 220 units per litre. Which pattern is this?
Which test is added to a raised alkaline phosphatase to confirm a hepatic origin?
Which marker is best for detecting a second myocardial infarction several days after the first?
A patient's alkaline phosphatase is raised and gamma-glutamyl transferase is normal. What is an important possible explanation?
Module summary and next
The clinical biochemistry of enzymes rests on one idea: cells leak when they die, and the leak has a characteristic size, tissue and time course. Cardiac markers report timing — a rise and then a fall — which is why serial measurement replaces a single value. Liver enzymes report the site of damage, through the ratio between transaminases and the biliary pair. And every value is measured against a reference range defined statistically across healthy people, so a mildly abnormal number is a probability to be interpreted, not a diagnosis.
Next module: carbohydrates, lipids and membranes — where the chemistry becomes the fuel and the barrier, and where the molecules you have met as enzyme inhibitors (such as the statins) become the drugs.